CW
IBB icon

CIC Wealth’s iShares Biotechnology ETF IBB Stock Holding History

CIC Wealth’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$211K Buy
+1,448
New +$210K 0.05% 165
2024
Q1 		– Sell
-1,498
Closed -$204K – 164
2023
Q4 		$204K Buy
+1,498
New +$183K 0.06% 152
2023
Q3 		– Sell
-1,578
Closed -$200K – 154
2023
Q2 		$200K Sell
1,578
-250
-14% -$32.5K 0.07% 156
2023
Q1 		$236K Hold
1,828
– – 0.09% 140
2022
Q4 		$240K Buy
+1,828
New +$236K 0.1% 135

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

CIC Wealth's IBB Position: Q3 2024 in Review

CIC Wealth opened a new position in iShares Biotechnology ETF (IBB) in Q3 2024: 1,448 shares worth $211K. The stake represents 0.05% of the portfolio and ranks #165 among its holdings. This is a return to the name: CIC Wealth previously reported a position in IBB as recently as Q4 2023.

CIC Wealth first reported a position in IBB in Q4 2022 and has held it in 5 quarters since. The position peaked at $240K in Q4 2022. 895 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

  • CIC Wealth held 1,448 shares of iShares Biotechnology ETF worth $211K as of Q3 2024.
  • iShares Biotechnology ETF was a new CIC Wealth position in Q3 2024.
  • iShares Biotechnology ETF made up 0.05% of CIC Wealth's portfolio in Q3 2024, its #165 holding.
  • CIC Wealth first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 5 quarters since.
  • CIC Wealth's iShares Biotechnology ETF position peaked at $240K in Q4 2022.
  • 895 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on CIC Wealth's 13F filing for Q3 2024, filed 8 Nov 2024.